Lakhmir S. Chawla - 11 Feb 2025 Form 4 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Role
Director
Signature
/s/ J.P. Galda, as attorney-in-fact for Lakhmir S Chawla
Issuer symbol
REVB
Transactions as of
11 Feb 2025
Net transactions value
+$700
Form type
4
Filing time
13 Feb 2025, 18:14:40 UTC
Previous filing
02 Oct 2023
Next filing
31 Oct 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REVB Common Stock Award $700 +181 $3.87 181 11 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Grant under the 2021 Equity Incentive Plan. Vests 100% on date of grant.